Status:
COMPLETED
Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
Obtaining data on efficacy (e.g. complete ST-segment resolution) depending on the time of treatment initiation and safety of prehospital and early hospital thrombolysis with Metalyse® in a real life s...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male and female patient with suspected myocardial infarction, e.g. during transportation to the hospital by ambulance. No patient younger than 18 years.
- Possibility of obtaining relevant information concerning indication or contraindication of thrombolysis in each patient
- Typical chest pain with a duration of more than 30 minutes
- Definite infarction signs in a 12-lead-ECG with ST-elevation \> 0.1 millivolt (mV) in \> 2 leads or recent left bundle branch block with typical clinical signs
- Symptom onset \<= 6 hours
- Exclusion criteria:
- Patients older than 75 years (exception: patients appear much younger)
- Low body weight
- No persons under 18
- contraindications according to summary of product characteristics (SPC) for Metalyse
Exclusion
Key Trial Info
Start Date :
May 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT02194153
Start Date
May 1 2001
Last Update
July 18 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.